Dr Reddy's Laboratories says its Andhra plant gets two observations from USFDA

The US Food and Drug Administration (USFDA) completed a pre-approval inspection at the company's formulations manufacturing facility FTO 11 in Srikakulam, Andhra Pradesh on Thursday, Dr Reddy's said in a regulatory filing. The inspection was conducted from June 30, 2022 to July 7, 2022.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news